Brief: Point72 Asset Management Reports 8.4%Passive Stake In Inhibikase Therapeutics As Of Oct 9- SEC Filing
10/10/2024 21:56
Inhibikase Therapeutics Inc IKT.O :
* POINT72 ASSET MANAGEMENT REPORTS 8.4%PASSIVE STAKE IN
INHIBIKASE
THERAPEUTICS AS OF OCT 9- SEC FILING
Source text for Eikon: ID:n0000902664-24-005789
Further company coverage: IKT.O
Recent news on Inhibikase Therapeutics
See all newsBrief: Inhibikase Therapeutics Appoints Scott Wasserman To Board Of Directors
Inhibikase Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Inhibikase Q2 net loss widens on higher R&D, SG&A costs
Inhibikase Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Brief: Inhibikase Therapeutics Prices Public Offering Of 46 Million Shares At $1.45 Per Share